ARFGAP2
Basic information
Region (hg38): 11:47164299-47177125
Previous symbols: [ "ZNF289" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ARFGAP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 37 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 37 | 1 | 0 |
Variants in ARFGAP2
This is a list of pathogenic ClinVar variants found in the ARFGAP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-47165478-C-T | ARFGAP2-related disorder | Benign (Oct 28, 2019) | ||
11-47165490-A-T | not specified | Uncertain significance (Sep 02, 2024) | ||
11-47165493-C-T | ARFGAP2-related disorder | Likely benign (Feb 23, 2022) | ||
11-47166272-A-C | not specified | Uncertain significance (Feb 27, 2025) | ||
11-47166315-C-G | not specified | Uncertain significance (Jan 21, 2025) | ||
11-47166368-T-A | not specified | Uncertain significance (Jul 20, 2021) | ||
11-47166512-C-T | not specified | Uncertain significance (Aug 28, 2024) | ||
11-47166777-G-A | not specified | Uncertain significance (Jan 26, 2023) | ||
11-47166830-G-A | not specified | Uncertain significance (Mar 07, 2025) | ||
11-47166843-C-T | not specified | Uncertain significance (Sep 11, 2024) | ||
11-47166858-G-A | not specified | Uncertain significance (Dec 16, 2023) | ||
11-47166875-C-T | not specified | Uncertain significance (Nov 04, 2023) | ||
11-47166876-G-A | ARFGAP2-related disorder | Benign (Oct 04, 2019) | ||
11-47166879-T-G | not specified | Uncertain significance (Dec 19, 2022) | ||
11-47167924-C-T | not specified | Uncertain significance (May 31, 2023) | ||
11-47167946-C-G | not specified | Uncertain significance (Oct 06, 2023) | ||
11-47167955-T-C | not specified | Uncertain significance (Aug 22, 2023) | ||
11-47167956-C-G | not specified | Uncertain significance (Feb 22, 2025) | ||
11-47168005-C-T | not specified | Uncertain significance (Mar 29, 2024) | ||
11-47168012-T-C | not specified | Uncertain significance (Aug 22, 2023) | ||
11-47168017-C-T | not specified | Uncertain significance (Sep 27, 2022) | ||
11-47168147-C-T | not specified | Uncertain significance (Feb 03, 2022) | ||
11-47168175-A-T | not specified | Uncertain significance (Mar 03, 2025) | ||
11-47168177-C-A | ARFGAP2-related disorder | Likely benign (Dec 18, 2019) | ||
11-47168177-C-T | ARFGAP2-related disorder | Benign (Jul 12, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ARFGAP2 | protein_coding | protein_coding | ENST00000524782 | 16 | 12829 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00489 | 0.995 | 125732 | 0 | 16 | 125748 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.697 | 275 | 309 | 0.889 | 0.0000175 | 3397 |
Missense in Polyphen | 74 | 105.79 | 0.69947 | 1143 | ||
Synonymous | -0.101 | 119 | 118 | 1.01 | 0.00000687 | 991 |
Loss of Function | 3.54 | 10 | 31.4 | 0.318 | 0.00000159 | 348 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000181 | 0.000181 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000616 | 0.0000615 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: GTPase-activating protein (GAP) for ADP ribosylation factor 1 (ARF1). Implicated in coatomer-mediated protein transport between the Golgi complex and the endoplasmic reticulum. Hydrolysis of ARF1-bound GTP may lead to dissociation of coatomer from Golgi-derived membranes to allow fusion with target membranes. {ECO:0000269|PubMed:17760859}.;
- Pathway
- Endocytosis - Homo sapiens (human);Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;COPI-dependent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;COPI-mediated anterograde transport;ER to Golgi Anterograde Transport;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Recessive Scores
- pRec
- 0.129
Intolerance Scores
- loftool
- rvis_EVS
- 0.53
- rvis_percentile_EVS
- 80.88
Haploinsufficiency Scores
- pHI
- 0.454
- hipred
- N
- hipred_score
- 0.426
- ghis
- 0.483
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.486
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Arfgap2
- Phenotype
Gene ontology
- Biological process
- endoplasmic reticulum to Golgi vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;protein transport;positive regulation of GTPase activity;COPI coating of Golgi vesicle
- Cellular component
- Golgi membrane;Golgi apparatus;trans-Golgi network;cytosol;plasma membrane;COPI vesicle coat
- Molecular function
- GTPase activator activity;metal ion binding